Weiner D A
Boston University School of Medicine, Massachusetts.
Med Clin North Am. 1988 Jan;72(1):83-115. doi: 10.1016/s0025-7125(16)30787-8.
The calcium channel blockers initially were approved for the treatment of classical and variant angina pectoris. Recent studies indicate that these agents also are useful in such diverse conditions as pulmonary and systemic hypertension, hypertrophic cardiomyopathy, arrhythmias, asthma, Raynaud's syndrome, esophageal spasm, myometrial hyperactivity, cerebral arterial spasm, and migraine.
钙通道阻滞剂最初被批准用于治疗典型和变异型心绞痛。最近的研究表明，这些药物在诸如肺动脉高压和系统性高血压、肥厚型心肌病、心律失常、哮喘、雷诺综合征、食管痉挛、子宫肌层活动亢进、脑动脉痉挛和偏头痛等多种病症中也很有用。
